Suprefort — EU research guide.
Suprefort is a Khavinson-series peptide bioregulator derived from pancreatic tissue, proposed to support beta-cell gene regulation and pancreatic reserve in aging models. It is the natural-complex counterpart to Pancragen, the synthetic tetrapeptide in the same research family.
What is Suprefort?
Suprefort is a Khavinson-series peptide bioregulator derived from pancreatic tissue, proposed to support beta-cell gene regulation and pancreatic reserve in aging models. It is the natural-complex counterpart to Pancragen, the synthetic tetrapeptide in the same research family.
What does the research show?
Available data is limited to small Eastern European cohort and animal studies on metabolic aging markers. No independently replicated controlled trials are publicly available as of mid-2026.
EU legal status
Not approved as a medicine anywhere in the EU. Sold by a small number of specialist research vendors for laboratory use only.
Molecular information
Pharmacokinetics
Suprefort is not yet in our price comparison
We expand EU supplier coverage every month.